Forward Pharma A/S (FWP) Reaches $4.00 Low on Dec, 6; Darden Restaurants (DRI) Has 0.95 Sentiment

December 6, 2017 - By Adrian Erickson

Darden Restaurants, Inc., through its subsidiaries, owns and operates full-service restaurants in the United States and Canada. The company has market cap of $10.58 billion. As of June 27, 2017, it owned and operated approximately 1,700 restaurants under the Olive Garden, LongHorn Steakhouse, Cheddar's Scratch Kitchen, Yard House, The Capital Grille, Seasons 52, Bahama Breeze, and Eddie V's brands. It has a 22.14 P/E ratio.

The stock of Forward Pharma A/S (NASDAQ:FWP) reached all time low today, Dec, 6 and still has $3.76 target or 6.00% below today’s $4.00 share price. This indicates more downside for the $188.74 million company. This technical setup was reported by Barchart.com. If the $3.76 PT is reached, the company will be worth $11.32 million less. The stock decreased 2.68% or $0.11 during the last trading session, reaching $4. About 43,363 shares traded. Forward Pharma A/S (NASDAQ:FWP) has risen 4.69% since December 6, 2016 and is uptrending. It has underperformed by 12.01% the S&P500.

Analysts await Darden Restaurants, Inc. (NYSE:DRI) to report earnings on December, 19. They expect $0.69 EPS, up 7.81% or $0.05 from last year’s $0.64 per share. DRI’s profit will be $85.34 million for 30.99 P/E if the $0.69 EPS becomes a reality. After $0.99 actual EPS reported by Darden Restaurants, Inc. for the previous quarter, Wall Street now forecasts -30.30% negative EPS growth.

Westport Asset Management Inc holds 3.11% of its portfolio in Darden Restaurants, Inc. for 40,000 shares. Covington Investment Advisors Inc. owns 76,545 shares or 2.65% of their US portfolio. Moreover, American International Group Inc has 2% invested in the company for 6.20 million shares. The Wisconsin-based Morgan Dempsey Capital Management Llc has invested 1.99% in the stock. Renaissance Group Llc, a Kentucky-based fund reported 415,916 shares.

Ratings analysis reveals 33% of Darden Restaurants’s analysts are positive. Out of 6 Wall Street analysts rating Darden Restaurants, 2 give it “Buy”, 1 “Sell” rating, while 3 recommend “Hold”. The lowest target is $50.0 while the high is $74.0. The stock’s average target of $62 is -27.50% below today’s ($85.52) share price. DRI was included in 6 notes of analysts from October 3, 2016. The stock of Darden Restaurants, Inc. (NYSE:DRI) earned “Mkt Perform” rating by Raymond James on Tuesday, October 18. The firm has “Buy” rating by Argus Research given on Thursday, January 5. The firm has “Buy” rating given on Thursday, December 1 by Guggenheim. The stock of Darden Restaurants, Inc. (NYSE:DRI) earned “Neutral” rating by Credit Suisse on Tuesday, November 29. On Monday, October 3 the stock rating was maintained by Stifel Nicolaus with “Sell”. Maxim Group downgraded Darden Restaurants, Inc. (NYSE:DRI) on Monday, November 28 to “Hold” rating.

The stock decreased 0.72% or $0.62 during the last trading session, reaching $85.52. About 971,264 shares traded. Darden Restaurants, Inc. (DRI) has risen 31.96% since December 6, 2016 and is uptrending. It has outperformed by 15.26% the S&P500.

Forward Pharma A/S operates as a biopharmaceutical company. The company has market cap of $188.74 million. The firm focuses on developing FP187, a proprietary formulation of dimethyl fumarate, which has been completed Phase II clinical trials used for the treatment of various inflammatory and neurological indications, including multiple sclerosis and other immune disorders, such as psoriasis. It has a 0.21 P/E ratio.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Adrian Erickson




Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: